GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Price-to-Funds-From-Operations

AdAlta (ASX:1AD) Price-to-Funds-From-Operations : (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


AdAlta (ASX:1AD) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.